Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Evolving Practices: Navigating Patient Care in Newly Diagnosed & R/R Multiple Myeloma - Episode 2
Guideline Recommendations for Risk Stratification
September 30, 2025
Sagar Lonial, MD, FACP, FASCP
,
Sandra Mazzoni, DO
EP. 1: Preferred Induction Regimen for Transplant-Eligible Patients with Newly-diagnosed Multiple Myeloma
Now Viewing
EP. 2: Guideline Recommendations for Risk Stratification
EP. 3: Selecting Between Quadruplet Induction Regimens
EP. 4: Managing Adverse Events for Patients Receiving Quadruplet Induction Regimens
EP. 5: Selecting the Proper Maintenance Therapy
EP. 6: Exploring Minimal Residual Disease in Multiple Myeloma
EP. 7: Frontline Induction Therapy for Transplant-Ineligible or Transplant-Deferred Patients
EP. 8: Bispecific Antibody Therapies for Relapsed or Refractory Multiple Myeloma
EP. 9: Step-up Dosing with Bispecifics
EP. 10: Aligning Real-world and Clinical Trial Data
EP. 11: Adverse Event Management with Bispecifics
EP. 12: Dose Modifications with Bispecifics
EP. 13: Real-world Outcomes with Talquetamab
EP. 14: Operationalizing Bispecifics with Other Sites